These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6413262)

  • 41. Gonadotropin releasing hormone agonists and the induction or augmentation of ovulation.
    Martin MC
    J Reprod Med; 1989 Dec; 34(12 Suppl):1034-8. PubMed ID: 2533619
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effects of bromocriptine on FSH and LH secretion in women with euprolactinemic anovulation (author's transl)].
    Mori H; Aisaka K; Kigawa T; Minakuchi H; Sakamoto S
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Oct; 33(10):1741-8. PubMed ID: 6796631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bromocriptine response in normoprolactinemic patients with polycystic ovary disease: a preliminary report.
    Seibel MM; Oskowitz S; Kamrava M; Taymor ML
    Obstet Gynecol; 1984 Aug; 64(2):213-9. PubMed ID: 6234484
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in plasma luteinizing hormone-releasing hormone during clomiphene-induced ovulatory cycles.
    Miyake A; Aono T; Minagawa J; Kawamura Y; Kurachi K
    Fertil Steril; 1980 Aug; 34(2):172-4. PubMed ID: 6773820
    [No Abstract]   [Full Text] [Related]  

  • 45. Normoprolactinemic anovulation nonresponsive to clomiphene citrate: ovulation induction with bromocriptine.
    Porcile A; Gallardo E; Venegas E
    Fertil Steril; 1990 Jan; 53(1):50-5. PubMed ID: 2295347
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of ovulation and pregnancy with HU-FSH (Metrodin) in women with polycystic ovarian disease: summary of clinical experience.
    Venturoli S; Fabbri R; Paradisi R; Magrini O; Porcu E; De Tomasi F; Flamigni C
    Acta Eur Fertil; 1983; 14(1):29-34. PubMed ID: 6426231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of metergoline on serum prolactin stimulated by TRH.
    Iannotta F; Gadaleta G; Pollini C; Vettaro MP
    J Endocrinol Invest; 1980; 3(3):301-3. PubMed ID: 6776182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Utility of the gonadotropin releasing hormone stimulation test in the anovulatory patient].
    Moggi G; Giorgi G; Chisci R; Giusti G; Berti P; Mazzotta AP; Gattini M; Santomauro S; Simonini N; Dalle Luche A
    Minerva Ginecol; 1977 Nov; 29(11):877-9. PubMed ID: 345153
    [No Abstract]   [Full Text] [Related]  

  • 49. Suppression of gonadotropin secretion and prevention of ovulation in the rat by antiserum to synthetic gonadotropin-releasing hormone.
    Koch Y; Chobsieng P; Zor U; Fridkin M; Lindner HR
    Biochem Biophys Res Commun; 1973 Dec; 55(3):623-9. PubMed ID: 4586615
    [No Abstract]   [Full Text] [Related]  

  • 50. Metergoline and bromocriptine in the management of tumoral and idiopathic hyperprolactinemia.
    Falsetti L; Roggia A; Loda G; Turla R; Scagliola T; Schimberni M; Pontiroli AE
    Horm Metab Res; 1983 Aug; 15(8):380-4. PubMed ID: 6618428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma melatonin profile and hormonal interactions in the menstrual cycles of anovulatory infertile women treated with gonadotropins.
    Tang PL; Chan TY; Tang GW; Pang SF
    Gynecol Obstet Invest; 1998; 45(4):247-52. PubMed ID: 9623790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Transient hyperprolactinemia during ovulation induction with gonadotropin releasing hormone (GnRH) pulsatile administration].
    Kuroda G; Tomioka N; Suginami H; Matsuura S
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):785-91. PubMed ID: 3298470
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Metergoline in hyperprolactinemic breast cancer: a phase II study].
    Holtkamp W; Nagel GA
    Onkologie; 1986 Oct; 9(5):245-8. PubMed ID: 3101016
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Induction of ovulation].
    Andreoli C
    Minerva Ginecol; 1974 Mar; 26(3):147-58. PubMed ID: 4601305
    [No Abstract]   [Full Text] [Related]  

  • 55. Endocrine profile and therapeutic employment of a new prolactin-lowering drug, metergoline.
    Ferrari C; Reschini E; Peracchi M; Crosignani PG
    Gynecol Obstet Invest; 1980; 11(1):1-16. PubMed ID: 6248438
    [No Abstract]   [Full Text] [Related]  

  • 56. Induction of ovulation in amenorrheic patients with gonadotropin-releasing hormone and human menopausal gonadotropin.
    Eckstein N; Vagman I; Eshel A; Naor Z; Ayalon D
    Fertil Steril; 1985 Dec; 44(6):744-50. PubMed ID: 3935484
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
    Farrari C; Telloli P; Rampini P; Caldara R
    Gynecol Obstet Invest; 1980; 11(6):317-26. PubMed ID: 6785158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of ovulation with luprolide acetate and human menopausal gonadotropin.
    Lewinthal D; Taylor PJ; Pattinson HA; Corenblum B
    Fertil Steril; 1988 Apr; 49(4):585-8. PubMed ID: 3127242
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ovulation induction with pulsatile luteinizing releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: clinical results.
    Burger CW; Korsen TJ; Hompes PG; van Kessel H; Schoemaker J
    Fertil Steril; 1986 Dec; 46(6):1045-54. PubMed ID: 3096792
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pulsatile subcutaneous low-dose gonadotropin-releasing hormone treatment of anovulatory infertility.
    Skarin G; Nillius SJ; Wide L
    Fertil Steril; 1983 Oct; 40(4):454-60. PubMed ID: 6413261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.